EICHORCondition: Prostatic Neoplasms · Sponsor: Novartis Pharmaceuticals
The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care (SOC), versus Standard of Care alone, in adult male patients with Metastatic hormone sensitive prostate cancer (mHSPC). In this study, the SoC is defined as a combination of Androgen Receptor Directed Therapy + Androgen Deprivation Therapy. Approximately 1126 patients will be randomized in this study. As of 31-Jan-2024, 1144 participants were enrolled in 20 countries.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Mayo Clinic - Arizona Mayo Clinic Hospital | Scottsdale, Arizona, United States | — |
| Mayo Clinic Arizona | Scottsdale, Arizona, United States | — |
| University of California San Diego - Moores Cancer Center | La Jolla, California, United States | — |
| VA Greater LA Healthcare System | Los Angeles, California, United States | — |
| University of California LA | Los Angeles, California, United States | — |
| St. Joseph Hospital | Orange, California, United States | — |
| Univ Cali Irvine ALS Neuromuscular | Orange, California, United States | — |
| VA Palo Alto Health Care System | Palo Alto, California, United States | — |
| Stanford University Medical Center | Palo Alto, California, United States | — |
| Sansum Clinic | Santa Barbara, California, United States | — |
| Providence Saint Johns Health Ctr | Santa Monica, California, United States | — |
| Univ Of Color Anschutz Med Center | Aurora, Colorado, United States | — |
+ 155 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04720157